The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis
Open accessAbstract
OBJECTIVE: To evaluate the accumulated information from genetic association studies investigating the impact of variants of the cytochrome P450 (CYP) 2C19 genotype on the clinical efficacy of clopidogrel. DESIGN: Systematic review and meta-analysis with a structured search algorithm and prespecified eligibility criteria for retrieval of relevant studies; dominant genetic model assumptions and quantitative methods for calculating summary effect estimates from study level odds ratios; systematic assessment of bias within and between studies; and grading of the cumulative evidence by consensus criteria. DATA SOURCES: Medline, Embase, the Cochrane Library, online databases, contents pages and bibliographies of general medical, cardiovascular, pharmacological, and genetic journals. Eligibility criteria for selecting studies Original full length reports assessing the cumulative incidence of major adverse cardiovascular events or stent thrombosis over a follow-up period of at least a month in association with carrier status for the loss of function or gain of function CYP2C19 allele in adult patients with coronary artery disease and a clinical presentation of acute coronary syndrome or stable angina pectoris who were taking clopidogrel. RESULTS: 15 studies met the inclusion criteria. The random effects summary odds ratio for stent thrombosis in carriers of at least one CYP2C19 loss of function allele versus non-carriers combining nine studies was 1.77 (95% confidence interval 1.31 to 2.40; P < 0.001). This nominally significant odds ratio was subject to considerable bias across the studies (small study effect bias and replication diversity). The adjustment for these quality modifiers tended to abolish the association. The corresponding random effects summary odds ratio of major adverse cardiovascular events for 12 studies combined was 1.11 (0.89 to 1.39; P = 0.36). The random effects summary odds ratio of stent thrombosis in carriers versus non-carriers of at least one CYP2C19*17 gain of function allele for three studies combined was 0.99 (0.60 to 1.62; P = 0.96), and the corresponding odds ratio of major adverse cardiovascular events in five studies was 0.93 (0.75 to 1.14; P = 0.48). The overall quality of epidemiological evidence was graded as low, which excludes reliable clinical assessments. CONCLUSIONS: Accumulated information from genetic association studies does not indicate a substantial or consistent influence of CYP2C19 gene polymorphisms on the clinical efficacy of clopidogrel. The current evidence does not support the use of individualised antiplatelet regimens guided by CYP2C19 genotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
(2014) · Medical Entomology and Zoology · Cited by 17,633
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
Cutlip, D. E., Windecker, S., Mehran, R., Boam, A., Cohen, D. J., van Es, G.-A., Gabriel Steg, P., Morel, M.-A., Mauri, L., Vranckx, P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.685313 · Cited by 5,497
Performing the Exact Test of Hardy-Weinberg Proportion for Multiple Alleles
Guo, S. W., & Thompson, E. A. (1992) · Biometrics · doi:10.2307/2532296 · Cited by 4,880
Funnel plots for detecting bias in meta-analysis
Sterne, J. A. C., & Egger, M. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00377-8 · Cited by 3,779
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
Mega, J. L., Close, S. L., Wiviott, S. D., Shen, L., Hockett, R. D., Brandt, J. T., Walker, J. R., Antman, E. M., Macias, W., Braunwald, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809171 · Cited by 2,497
Comparison of two methods to detect publication bias in meta-analysis.
Peters, J. L. (2006) · JAMA · doi:10.1001/jama.295.6.676 · Cited by 2,278
A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints
Harbord, R. M., Egger, M., & Sterne, J. A. C. (2006) · Statistics in Medicine · doi:10.1002/sim.2380 · Cited by 2,267
Replication validity of genetic association studies
Ioannidis, J. P. A., Ntzani, E. E., Trikalinos, T. A., & Contopoulos-Ioannidis, D. G. (2001) · Nature Genetics · doi:10.1038/ng749 · Cited by 1,832
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
Simon, T., Verstuyft, C., Mary-Krause, M., Quteineh, L., Drouet, E., Méneveau, N., Steg, P. G., Ferrières, J., Danchin, N., & Becquemont, L. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808227 · Cited by 1,728
Shuldiner, A. R. (2009) · JAMA · doi:10.1001/jama.2009.1232 · Cited by 1,505
Uncertainty in heterogeneity estimates in meta-analyses
Ioannidis, J. P. A., Patsopoulos, N. A., & Evangelou, E. (2007) · BMJ · doi:10.1136/bmj.39343.408449.80 · Cited by 1,254
Clopidogrel with or without Omeprazole in Coronary Artery Disease
Bhatt, D. L., Cryer, B. L., Contant, C. F., Cohen, M., Lanas, A., Schnitzer, T. J., Shook, T. L., Lapuerta, P., Goldsmith, M. A., Laine, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007964 · Cited by 1,240
Bonello, L., Tantry, U. S., Marcucci, R., Blindt, R., Angiolillo, D. J., Becker, R., Bhatt, D. L., Cattaneo, M., Collet, J. P., Cuisset, T., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.047 · Cited by 1,149
Self-citationCumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction
Lau, J., Antman, E. M., Jimenez-Silva, J., Kupelnick, B., Mosteller, F., & Chalmers, T. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207233270406 · Cited by 1,140
Patsopoulos, N. A., Evangelou, E., & Ioannidis, J. P. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn065 · Cited by 1,138
Mega, J. L., Simon, T., Collet, J.-P., Anderson, J. L., Antman, E. M., Bliden, K., Cannon, C. P., Danchin, N., Giusti, B., Gurbel, P., et al. (2010) · JAMA · doi:10.1001/jama.2010.1543 · Cited by 1,135
King, S. B., Smith, S. C., Hirshfeld, J. W., Jacobs, A. K., Morrison, D. A., Williams, D. O., 2005 WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.188208 · Cited by 1,014
Collet, J.-P., Hulot, J.-S., Pena, A., Villard, E., Esteve, J.-B., Silvain, J., Payot, L., Brugier, D., Cayla, G., Beygui, F., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61845-0 · Cited by 967
Hulot, J.-S. (2006) · Blood · doi:10.1182/blood-2006-04-013052 · Cited by 931
Breet, N. J., van Werkum, J. W., Bouman, H. J., Kelder, J. C., Ruven, H. J. T., Bal, E. T., Deneer, V. H., Harmsze, A. M., van der Heyden, J. A. S., Rensing, B. J. W. M., et al. (2010) · JAMA · doi:10.1001/jama.2010.181 · Cited by 850
Self-citationKazui, M., Nishiya, Y., Ishizuka, T., Hagihara, K., Farid, N. A., Okazaki, O., Ikeda, T., & Kurihara, A. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.029132 · Cited by 835
Wallentin, L., James, S., Storey, R. F., Armstrong, M., Barratt, B. J., Horrow, J., Husted, S., Katus, H., Steg, P. G., Shah, S. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61274-3 · Cited by 799
Composite Outcomes in Randomized Trials: Greater Precision But With Greater Uncertainty?
Freemantle, N., Calvert, M., Wood, J., Eastaugh, J., & Griffin, C. (2003) · JAMA · doi:10.1001/jama.289.19.2554 · Cited by 783
SIM, S., RISINGER, C., DAHL, M., AKLILLU, E., CHRISTENSEN, M., BERTILSSON, L., & INGELMANSUNDBERG, M. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.10.002 · Cited by 732
Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent Thrombosis
Buonamici, P., Marcucci, R., Migliorini, A., Gensini, G. F., Santini, A., Paniccia, R., Moschi, G., Gori, A. M., Abbate, R., & Antoniucci, D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.094 · Cited by 656
Sibbing, D., Braun, S., Morath, T., Mehilli, J., Vogt, W., Schömig, A., Kastrati, A., & von Beckerath, N. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.030 · Cited by 651
Sibbing, D., Koch, W., Gebhard, D., Schuster, T., Braun, S., Stegherr, J., Morath, T., Schömig, A., von Beckerath, N., & Kastrati, A. (2010) · Circulation · doi:10.1161/circulationaha.109.885194 · Cited by 585
Assessment of cumulative evidence on genetic associations: interim guidelines
Ioannidis, J. P., Boffetta, P., Little, J., O'Brien, T. R., Uitterlinden, A. G., Vineis, P., Balding, D. J., Chokkalingam, A., Dolan, S. M., Flanders, W. D., et al. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dym159 · Cited by 552
Trenk, D., Hochholzer, W., Fromm, M. F., Chialda, L.-E., Pahl, A., Valina, C. M., Stratz, C., Schmiebusch, P., Bestehorn, H.-P., Büttner, H. J., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.12.056 · Cited by 540
Effects of CYP2C19 Genotype on Outcomes of Clopidogrel Treatment
Paré, G., Mehta, S. R., Yusuf, S., Anand, S. S., Connolly, S. J., Hirsh, J., Simonsen, K., Bhatt, D. L., Fox, K. A. A., & Eikelboom, J. W. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008410 · Cited by 534
Lau, W. C., Gurbel, P. A., Watkins, P. B., Neer, C. J., Hopp, A. S., Carville, D. G. M., Guyer, K. E., Tait, A. R., & Bates, E. R. (2004) · Circulation · doi:10.1161/01.cir.0000112378.09325.f9 · Cited by 487
Bayesian statistical methods for genetic association studies
Stephens, M., & Balding, D. J. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2615 · Cited by 468
Paraoxonase-1 is a major determinant of clopidogrel efficacy
Bouman, H. J., Schömig, E., van Werkum, J. W., Velder, J., Hackeng, C. M., Hirschhäuser, C., Waldmann, C., Schmalz, H.-G., ten Berg, J. M., & Taubert, D. (2011) · Nature Medicine · doi:10.1038/nm.2281 · Cited by 465
Self-citationSnoep, J. D., Hovens, M. M. C., Eikenboom, J. C. J., van der Bom, J. G., Jukema, J. W., & Huisman, M. V. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.04.014 · Cited by 427
Sibbing, D., Stegherr, J., Latz, W., Koch, W., Mehilli, J., Dorrler, K., Morath, T., Schomig, A., Kastrati, A., & von Beckerath, N. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehp041 · Cited by 418
Cordoba, G., Schwartz, L., Woloshin, S., Bae, H., & Gotzsche, P. C. (2010) · BMJ · doi:10.1136/bmj.c3920 · Cited by 400
Large sample variance of kappa in the case of different sets of raters.
Fleiss, J. L., Nee, J. C., & Landis, J. R. (1979) · Psychological Bulletin · doi:10.1037//0033-2909.86.5.974 · Cited by 398
Hulot, J.-S., Collet, J.-P., Silvain, J., Pena, A., Bellemain-Appaix, A., Barthélémy, O., Cayla, G., Beygui, F., & Montalescot, G. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.071 · Cited by 383
Clarke, T. A., & Waskell, L. A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.1.53 · Cited by 374
Zintzaras, E., & Lau, J. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.12.011 · Cited by 361
Random-Effects Meta-Analyses Are Not Always Conservative
Poole, C., & Greenland, S. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010035 · Cited by 338
Heterogeneity in Meta-Analyses of Genome-Wide Association Investigations
Ioannidis, J. P. A., Patsopoulos, N. A., & Evangelou, E. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000841 · Cited by 331
PBAT: tools for family-based association studies.
Lange, C., DeMeo, D., Silverman, E. K., Weiss, S. T., & Laird, N. M. (2004) · The American Journal of Human Genetics · doi:10.1086/381563 · Cited by 268
Charlot, M., Ahlehoff, O., Norgaard, M. L., Jørgensen, C. H., Sørensen, R., Abildstrøm, S. Z., Hansen, P. R., Madsen, J. K., Køber, L., Torp-Pedersen, C., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-6-201009210-00005 · Cited by 264
Lettre, G., Lange, C., & Hirschhorn, J. N. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20217 · Cited by 247
Rudberg, I., Mohebi, B., Hermann, M., Refsum, H., & Molden, E. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100291 · Cited by 232
Giusti, B., Gori, A. M., Marcucci, R., Saracini, C., Sestini, I., Paniccia, R., Buonamici, P., Antoniucci, D., Abbate, R., & Gensini, G. F. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.11.048 · Cited by 225
Man, M., Farmen, M., Dumaual, C., Teng, C. H., Moser, B., Irie, S., Noh, G. J., Njau, R., Close, S., Wise, S., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009355161 · Cited by 216
Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls
Kavvoura, F. K., & Ioannidis, J. P. A. (2008) · Human Genetics · doi:10.1007/s00439-007-0445-9 · Cited by 212
Ethical issues in stopping randomized trials early because of apparent benefit.
Mueller, P. S., Montori, V. M., Bassler, D., Koenig, B. A., & Guyatt, G. H. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00009 · Cited by 202
Clopidogrel non-responsiveness and risk of cardiovascular morbidity: An updated meta-analysis
Marcucci, R., Gori, A. M., Giusti, B., Abbate, R., Gensini, G. F., & Sofi, F. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-06-0418 · Cited by 200
Scholz, I., Oberwittler, H., Riedel, K., Burhenne, J., Weiss, J., Haefeli, W. E., & Mikus, G. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03534.x · Cited by 184
Sofi, F., Giusti, B., Marcucci, R., Gori, A. M., Abbate, R., & Gensini, G. F. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2010.21 · Cited by 172
Tiroch, K. A., Sibbing, D., Koch, W., Roosen-Runge, T., Mehilli, J., Schömig, A., & Kastrati, A. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.06.039 · Cited by 166
CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study
Harmsze, A. M., van Werkum, J. W., ten Berg, J. M., Zwart, B., Bouman, H. J., Breet, N. J., van 't Hof, A. W. J., Ruven, H. J. T., Hackeng, C. M., Klungel, O. H., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq321 · Cited by 161
Self-citationCytochrome P-450 Polymorphisms and Response to Clopidogrel
Taubert, D., Bouman, H. J., & van Werkum, J. W. (2009) · New England Journal of Medicine · doi:10.1056/nejmc090391 · Cited by 135
Self-citationHow to Use an Article About Genetic Association: B: Are the Results of the Study Valid?
Attia, J., Ioannidis, J. P. A., Thakkinstian, A., McEvoy, M., Scott, R. J., Minelli, C., Thompson, J. R., Infante‐Rivard, C., & Guyatt, G. H. (2009) · JAMA · doi:10.1001/jama.2008.946 · Cited by 131
Barbui, C., Dua, T., van Ommeren, M., Yasamy, M. T., Fleischmann, A., Clark, N. C., Thornicroft, G., Hill, S. R., & Saxena, S. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000322 · Cited by 128
The Effect That Genotyping Errors Have on the Robustness of Common Linkage-Disequilibrium Measures
Akey, J. M., Zhang, K., Xiong, M., Doris, P. A., & Li, J. (2001) · The American Journal of Human Genetics · doi:10.1086/320607 · Cited by 116
(2001) · New England Journal of Medicine · doi:10.1056/nejm200112063452321 · Cited by 103
Małek, Ł. A., Kisiel, B. M., Śpiewak, M., Grabowski, M., Filipiak, K. J., Kostrzewa, G., Huczek, Z., Płoski, R., & Opolski, G. (2008) · Circulation Journal · doi:10.1253/circj.72.1165 · Cited by 94
Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes
Yasui‐Furukori, N., Takahata, T., Nakagami, T., Yoshiya, G., Inoue, Y., Kaneko, S., & Tateishi, T. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2003.02047.x · Cited by 84
Sawada, T., Shinke, T., Shite, J., Honjo, T., Haraguchi, Y., Nishio, R., Shinohara, M., Toh, R., Ishida, T., Kawamori, H., et al. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0525 · Cited by 74
Jin, B., Ni, H., Shen, W., et al. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0282-0 · Cited by 51
The Case for Routine Genotyping in Dual-Antiplatelet Therapy
Damani, S. B., & Topol, E. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.029 · Cited by 49
Schenk, P. W., van Vliet, M., Mathôt, R. A. A., van Gelder, T., Vulto, A. G., van Fessem, M., Rij, S. V.-V., Lindemans, J. W., Bruijn, J. A., & van Schaik, R. H. N. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.50 · Cited by 46
Małek, Ł. A., Przyłuski, J., Śpiewak, M., Kłopotowski, M. M., Kostrzewa, G., Kruk, M. B. P., Płoski, R., Witkowski, A., & Rużyłło, W. (2010) · Cardiology · doi:10.1159/000320093 · Cited by 27
Stent thrombosis: who's guilty?
Montalescot, G., Hulot, J., & Collet, J. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp436 · Cited by 19
Cited by
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
Scott, S. A., Sangkuhl, K., Stein, C. M., Hulot, J.-S., Mega, J. L., Roden, D. M., Klein, T. E., Sabatine, M. S., Johnson, J. A., & Shuldiner, A. R. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.105 · Cited by 962
Holmes, M. V., Perel, P., Shah, T., Hingorani, A. D., & Casas, J. P. (2011) · JAMA · doi:10.1001/jama.2011.1880 · Cited by 472
Wang, Y., Zhao, X., Lin, J., Li, H., Johnston, S. C., Lin, Y., Pan, Y., Liu, L., Wang, D., Wang, C., et al. (2016) · JAMA · doi:10.1001/jama.2016.8662 · Cited by 375
Applications of CYP450 Testing in the Clinical Setting
Samer, C. F., Lorenzini, K. I., Rollason, V., Daali, Y., & Desmeules, J. A. (2013) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0028-5 · Cited by 354
Metadata
- Authors
- Bauer, T., Bouman, H. J., van Werkum, J. W., Ford, N. F., ten Berg, J. M., & Taubert, D.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2011-08-04
- Volume
- 343
- Issue
- aug04 1
- Pages
- d4588-d4588
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2037355442
- Cited by
- 266
- References
- 75
- FWCI
- 7.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.